Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma

Cancer Treat Rep. 1984 Sep;68(9):1199-200.
No abstract available

MeSH terms

  • Adult
  • Aged
  • Drug Administration Schedule
  • Drug Evaluation
  • Female
  • Humans
  • Infusions, Parenteral
  • Male
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Middle Aged
  • Vinblastine / administration & dosage
  • Vinblastine / adverse effects
  • Vinblastine / analogs & derivatives*
  • Vinblastine / therapeutic use
  • Vindesine

Substances

  • Vinblastine
  • Vindesine